World Journal of Surgery

, Volume 28, Issue 6, pp 602–608 | Cite as

Pancreaticoduodenectomy with En Bloc Portal Vein Resection for Pancreatic Carcinoma with Suspected Portal Vein Involvement

  • Ronnie T. Poon
  • Sheung Tat Fan
  • Chung Mau Lo
  • Chi Leung Liu
  • Chi Ming Lam
  • Wai Key Yuen
  • Chun Yeung
  • John Wong
Original Scientific Reports

Abstract

Pancreaticoduodenectomy combined with portal vein resection is increasingly accepted as a viable treatment option for pancreatic carcinoma with suspected involvement of the portal vein.However, its clinical benefit remains controversial. This study evaluated the outcomes of pancreaticoduodenectomy with portal vein resection for pancreatic carcinoma in a group of Chinese patients operated on by a specialized team in a center with a low case volume of pancreatic cancer. The perioperative and long-term outcomes of 12 patients with portal vein resection for suspected involvement of the portal vein and 38 patients who underwent pancreaticoduodenectomy without portal vein resection during the same period were compared. In the former group, eight patients underwent segmental resection, and four patients underwent wedge resection of the portal vein. There were no significant differences in operative blood loss (median 0.8 vs. 0.8 liter, p = 0.313), hospital mortality (0% vs. 2.6%, p = 1.000), or operative morbidity (41.7% vs. 42.1%, p = 0.979) between the two groups. Patients who required portal vein resection had higher frequencies of microscopic lymphatic permeation (58.3% vs. 18.4%, p = 0.023) and vascular invasion (50.0% vs. 15.8%, p = 0.025). Long-term survival was comparable between patients with portal vein resection and those without it (median 19.5 vs. 20.7 months, p = 0.769). These findings suggest that pancreaticoduodenectomy combined with portal vein resection can be performed safely by a specialized team in a center with a low case volume of pancreatic carcinoma and that it may offer survival benefit in patients with suspected portal vein involvement.

References

  1. 1.
    Yeo, CJ, Cameron, JL, Lillemoe, KD,  et al. 1995Pancreaticoduodenectomy for cancer of the head of the pancreas, 201 patientsAnn. Surg.221721733PubMedGoogle Scholar
  2. 2.
    Fernandez-del Castillo, C, Rattner, DW, Warshaw, AL 1995Standards for pancreatic resection in the 1990sArch. Surg.130295300PubMedGoogle Scholar
  3. 3.
    Neoptolemos, JP, Russell, RC, Bramhall, S,  et al. 1997Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units; UK Pancreatic Cancer GroupBr. J. Surg.8413701376CrossRefPubMedGoogle Scholar
  4. 4.
    Bramhall, SR, Allum, WH, Jones, AG,  et al. 1995Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological studyBr. J. Surg.82111115PubMedGoogle Scholar
  5. 5.
    Sener, SF, Fremgen, A, Menck, HR,  et al. 1999Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer DatabaseJ. Am. Coll. Surg.18917CrossRefPubMedGoogle Scholar
  6. 6.
    Sindelar, WF 1989Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreasArch. Surg.124127132PubMedGoogle Scholar
  7. 7.
    Cameron, JL, Crist, DW, Sitzmann, JV,  et al. 1991Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer: factors influencing survival after pancreaticoduodenectomy for pancreatic cancerAm. J. Surg.161120125CrossRefPubMedGoogle Scholar
  8. 8.
    Harrison, LE, Klimstra, DS, Brennan, MF 1996Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection?Ann. Surg.224342349CrossRefPubMedGoogle Scholar
  9. 9.
    Fuhrman, GM, Leach, SD, Staley, CA,  et al. 1996Rationale for en-bloc vein resection in the treatment of pancreatic adenocarcinoma adjacent to the superior mesenteric-portal vein confluencePancreatic Tumor Study Group. Ann. Surg.223154162CrossRefGoogle Scholar
  10. 10.
    Leach, SD, Lee, JE, Charnsangavej, C,  et al. 1998Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic headBr. J. Surg.85611617CrossRefPubMedGoogle Scholar
  11. 11.
    Allema, JH, Reinders, ME, Gulik, TM,  et al. 1994Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic headBr. J. Surg.8116421646PubMedGoogle Scholar
  12. 12.
    Roder, JD, Stein, HJ, Siewert, JR 1996Carcinoma of the periampullary region: who benefits from portal vein resection?Am. J. Surg.171170175CrossRefPubMedGoogle Scholar
  13. 13.
    Kremer, B, Vogel, I, Luttges, J,  et al. 1999Surgical possibilities for pancreatic cancer: extended resectionAnn. Oncol.10S252S256CrossRefGoogle Scholar
  14. 14.
    Launois, B, Stasik, C, Bardaxoglou, E,  et al. 1999Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?World J. Surg.23926929CrossRefPubMedGoogle Scholar
  15. 15.
    Geenen, RC, Kate, FJ, Wit, LT,  et al. 2001Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomySurgery129158163CrossRefPubMedGoogle Scholar
  16. 16.
    Luque-de Leon, E, Tsiotos, GG, Balsiger, B,  et al. 1999Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rateJ. Gastrointestint. Surg.3111118CrossRefGoogle Scholar
  17. 17.
    Onoue, S, Katoh, T, Chigira, H,  et al. 2002Carcinoma of the head of the pancreasHepatogastroenterology.49549552PubMedGoogle Scholar
  18. 18.
    Shibata, C, Kobari, M, Tsuchiya, T,  et al. 2001Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreasWorld J. Surg.2510021005CrossRefPubMedGoogle Scholar
  19. 19.
    Aramaki, M, Matsumoto, T, Etoh, T,  et al. 2003Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinomaHepatogastroenterology.50263266PubMedGoogle Scholar
  20. 20.
    Longnecker, DS, Karagas, MR, Tosteson, TD,  et al. 2000Racial differences in pancreatic cancer: comparison of survival and histologic types of pancreatic carcinoma in Asians, blacks, and whites in the United StatesPancreas21338343CrossRefPubMedGoogle Scholar
  21. 21.
    Dong, M, Nio, Y, Tamura, K,  et al. 2000Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patientsCancer Epidemiol. Biomarkers Prev.9279284PubMedGoogle Scholar
  22. 22.
    Takada, T 1999Surgery for carcinoma of the pancreas in Japan: past, present and future aspectsDigestion60114119CrossRefPubMedGoogle Scholar
  23. 23.
    Poon, RT, Fan, ST 2001Opinions and commentary on treating pancreatic cancerSurg. Clin. North Am.81625636PubMedGoogle Scholar
  24. 24.
    Friess, H, Kleeff, J, Fischer, L,  et al. 2003Surgical standard therapy for cancer of the pancreasChirurg74183190CrossRefPubMedGoogle Scholar
  25. 25.
    Tashiro, S, Uchino, R, Hiraoka, T,  et al. 1991Surgical indication and significance of portal vein resection in biliary and pancreatic cancerSurgery109481487PubMedGoogle Scholar
  26. 26.
    Ishikawa, O, Ohigashi, H, Imaoka, S,  et al. 1992Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal veinAnn. Surg.215231236PubMedGoogle Scholar
  27. 27.
    Takahashi, S, Ogata, Y, Tsuzuki, T 1994Combined resection of the pancreas and portal vein for pancreatic cancerBr. J. Surg.8111901193PubMedGoogle Scholar
  28. 28.
    Nakao, A, Harada, A, Nonami, T,  et al. 1995Clinical significance of portal invasion by pancreatic head carcinomaSurgery1175055PubMedGoogle Scholar
  29. 29.
    Shibata, C, Kobari, M, Tsuchiya, T,  et al. 2001Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreasWorld J. Surg.2510021005CrossRefPubMedGoogle Scholar
  30. 30.
    Bachellier, P, Nakano, H, Oussoultzoglou, E,  et al. 2001Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?Am. J. Surg.182120129CrossRefPubMedGoogle Scholar
  31. 31.
    Kawada, M, Kondo, S, Okushiba, S,  et al. 2002Reevaluation of the indications for radical pancreatectomy to treat pancreatic carcinoma: is portal vein infiltration a contraindication?Surg. Today32598601CrossRefPubMedGoogle Scholar
  32. 32.
    Aramaki, M, Matsumoto, T, Etoh, T,  et al. 2003Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinomaHepatogastroenterology.50263266PubMedGoogle Scholar
  33. 33.
    Nakagorhi, T, Kinoshita, T, Konishi, M,  et al. 2003Survival benefits of portal vein resection for pancreatic cancerAm. J. Surg.186149153CrossRefPubMedGoogle Scholar
  34. 34.
    Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong 1997, Hong Kong, Hospital Authority, 1997Google Scholar
  35. 35.
    Boring, CC, Squires, TS, Tong, T,  et al. 1994Cancer statistics 1994CA. Cancer J. Clin.44726PubMedGoogle Scholar
  36. 36.
    Sosa, JA, Bowman, HM, Gordon, TA,  et al. 1998Importance of hospital volume in the overall management of pancreatic cancerAnn. Surg.228429438CrossRefPubMedGoogle Scholar
  37. 37.
    Birkmeyer, JD, Finlayson, SR, Tosteson, AN,  et al. 1999Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomySurgery125250256CrossRefPubMedGoogle Scholar
  38. 38.
    Gouma, DJ, Geenen, RC, Gulik, TM,  et al. 2000Rates of complications and deaths after pancreaticoduodenectomy: risk factors and the impact of hospital volumeAnn. Surg.232786795CrossRefPubMedGoogle Scholar
  39. 39.
    Ho, V, Heslin, MJ 2003Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomyAnn. Surg.237509514CrossRefPubMedGoogle Scholar
  40. 40.
    Strasberg, SM, Drebin, JA, Soper, NJ 1997Evolution and current status of the Whipple procedure: an update for gastroenterologistsGastroenterology113983994PubMedGoogle Scholar
  41. 41.
    Yeo, CJ, Cameron, JL, Sohn, TA,  et al. 1997Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomesAnn. Surg.226248260CrossRefPubMedGoogle Scholar
  42. 42.
    Yeo, CJ, Abrams, RA, Grochow, LB,  et al. 1997Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: a prospective, single-institution experienceAnn. Surg.225621636CrossRefPubMedGoogle Scholar
  43. 43.
    Klinkenbijl, JH, Jeekel, J, Sahmoud, T,  et al. 1999Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative groupAnn. Surg.230776784CrossRefPubMedGoogle Scholar
  44. 44.
    Neoptolemos, JP, Dunn, JA, Stocken, DD,  et al. 2001Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialLancet35815761585CrossRefPubMedGoogle Scholar
  45. 45.
    Mehta, VK, Fisher, G, Ford, JA,  et al. 2001Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreasJ. Gastrointest. Surg.52735CrossRefPubMedGoogle Scholar
  46. 46.
    Sasson, AR, Hoffman, JP, Ross, EA,  et al. 2002En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?J. Gastrointest. Surg.6147157CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2004

Authors and Affiliations

  • Ronnie T. Poon
    • 1
  • Sheung Tat Fan
    • 1
  • Chung Mau Lo
    • 1
  • Chi Leung Liu
    • 1
  • Chi Ming Lam
    • 1
  • Wai Key Yuen
    • 1
  • Chun Yeung
    • 1
  • John Wong
    • 1
  1. 1.Department of Surgery and Centre for the Study of Liver Disease, Queen Mary HospitalUniversity of Hong Kong Medical CentreHong KongChina

Personalised recommendations